Growth Platform Avista is building a growth-oriented healthcare platform with recent acquisitions and a new consumer health initiative (Birchwell Consumer Health), suggesting ongoing M&A activity and a push into consumer wellness brands. Sales opportunities may lie in portfolio company software, digital health, and consumer branding capabilities that support add-ons or integration across platforms.

Healthcare Focus The firm concentrates exclusively on healthcare, with a track record of investing in growth-oriented healthcare businesses and leveraging strategic executives to drive long-term value. Potential sales opportunities include healthcare IT, data analytics, and operations optimization services tailored to scale in regulated healthcare environments.

Scale Readiness Avista targets strong management teams, stable cash flows and robust growth prospects across six sub-sectors with tailwinds, indicating readiness for scalable, enterprise-grade solutions, recurring revenue models, and long-cycle partnerships that align with private equity portfolio deployment and exits.

Recent Deals Active deal flow includes Bentec Medical acquisition and the EBI Bone Healing Division sale, as well as the launch of Birchwell and acquisition of PK Benelux. These moves signal openness to technology-enabled medical devices, consumer health products, and cross-border integration, presenting opportunities for compliance, integration, and product lifecycle services.

Funding Capacity With a stated investment footprint of over $10 billion and revenue in the tens of millions range for portfolio companies, Avista demonstrates substantial buying power and potential for large-scale technology, platform investments, and strategic services across its ecosystem.